Englewood, United States
Neuroview Technology is a data-driven technology platform and medical device company focused on neurology outcomes. Founded in 2016 and headquartered in the United States, the company has developed a breakthrough device - a small implantable subcutaneous long-term brain monitor using EEG.
With the absence of any long-term electroencephalography (EEG) monitor devices approved by the FDA, Neuroview's technology fills a critical gap in the market. This is crucial as EEG studies, even if intensive, are limited to a few days, which provide scant information, especially for dynamic brain disorders like epilepsy.
Epilepsy affects nearly 4 million adults and children in the United States, with up to 30% not responding effectively to medical therapy. Neuroview's novel technology brings a transformative change by accurately identifying unrecognized seizures, preventing false characterization of events, and optimizing management, thus addressing the current reliance on subjective seizure reporting, which is only 40-50% accurate.
The recent $250.00K Venture Round investment on 19 December 2023 further underscores the potential of Neuroview's technology to make a significant impact in the healthcare industry. The company's commitment to data-driven decision-making (DDDM), employing AI/ML/DDN to analyze long-term EEG data, indicates a strong strategy to democratize and personalize healthcare, resulting in improved outcomes, reduced costs, and personalized care for brain disorders.
